ID/Version |
|
||||||||||||||
Sequence description from provider |
RecName: Full=Chromodomain-helicase-DNA-binding protein 2; Short=CHD-2; EC=3.6.4.12;AltName: Full=ATP-dependent helicase CHD2; | ||||||||||||||
Provider | SWISS-PROT | ||||||||||||||
Sequence |
Polypeptide
1827
aa
|
||||||||||||||
Source | |||||||||||||||
Annotated genes and markers |
Follow the symbol links to get more information on the GO terms,
expression assays, orthologs, phenotypic alleles, and other information
for the genes or markers below.
|
||||||||||||||
Sequence references in MGI |
J:146176
Nagarajan P, et al., Role of chromodomain helicase DNA-binding protein 2 in DNA damage response signaling and tumorigenesis. Oncogene. 2009 Feb 26;28(8):1053-62
J:146743 Marfella CG, et al., Mutation of the SNF2 family member Chd2 affects mouse development and survival. J Cell Physiol. 2006 Oct;209(1):162-71 J:204624 Harada A, et al., Chd2 interacts with H3.3 to determine myogenic cell fate. EMBO J. 2012 Jun 29;31(13):2994-3007 J:212063 Marfella CG, et al., A mutation in the mouse Chd2 chromatin remodeling enzyme results in a complex renal phenotype. Kidney Blood Press Res. 2008;31(6):421-32 J:292518 Huttlin EL, et al., A tissue-specific atlas of mouse protein phosphorylation and expression. Cell. 2010 Dec 23;143(7):1174-89 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|